Why Clinicians Should Care About PDABs
Q. Why should clinicians have a say on medication value? Clinicians, not PDABs or manufacturers, prescribe medications. We are the ones sitting with patients, evaluating, discussing and deciding which therapy would be best for them. PDAB “affordability” decisions are based on economics, not patient needs or outcomes. Read Q&A with Harry L. Gewanter, MD, FAAP, […]
Biologics in Respiratory Care
Q. How can biologics improve respiratory conditions? Biologics target the specific inflammatory pathways involved in the development of asthma, allergic diseases and other respiratory illnesses. This specificity allows for personalized treatment options because biologics attack different root causes of each disease. Read Q&A with James Tracy, DO >
Why is Lung Cancer Screening Crucial?
Jeffrey Velotta, MD, FACS, discusses the importance of screening for lung cancer. Read Q&A >
